In our pilot study, we demonstrated that CP administration decreased the expression levels of upregulated gene 11 (URG11) and developmentally regulated GTP binding protein 2 (DRG2) in preneoplastic HBV-associated HCC (Tong et al., 2014). Here, CP is linked to hepatocellular carcinoma.